D-0777-2023 Class II Terminated
FDA drug recall D-0777-2023 was initiated by Fresenius Medical Care Holdings, Inc. on May 23, 2023 and is designated Class II. Reason for recall: Lack of assurance of sterility: The product was potentially exposed to below-recommended storage temperatures, which may cause leaks in the packaging. The recall status is terminated (terminated May 23, 2024). Affected quantity: 53,424 bags.
Recall details
- Product Type
- Drugs
- Report Date
- Jun 7, 2023
- Initiation Date
- May 23, 2023
- Termination Date
- May 23, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 53,424 bags
Product description
Sodium Chloride 0.9% Injection, USP, 1000 mL bags, 12 bags per carton, Rx only, Fresenius Medical Care North America, Waltham, MA 02451, NDC # 49230-300-10
Reason for recall
Lack of assurance of sterility: The product was potentially exposed to below-recommended storage temperatures, which may cause leaks in the packaging.
Distribution pattern
Product was distributed to 32 clinics in SC, NC and VA.
Code information
Lot # 23AU05030, Exp 01/13/2024; 23AU05035, Exp 01/15/2024
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0777-2023
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026